| 综述 |
|
|
|
|
| 缝隙连接与糖尿病足 |
| 邹晓荣1, 陶剑1, 王云开2 |
1. 南昌大学第一附属医院高血压研究所, 江西 南昌 330006;
2. 南昌大学第一附属医院心内科, 江西 南昌 330006 |
|
| Gap junction and diabetic foot |
| ZOU Xiao-rong1, TAO Jian1, WANG Yun-kai2 |
1. Department of Hypertension Institute, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China;
2. Department of Cardiology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China |
| [1] |
PALATINUS J A, RHETT J M, GOURDIE R G. Enhanced PKCepsilon mediated phosphorylation of connexin43 at serine 368 by a carboxyl-terminal mimetic peptide is dependent on injury[J]. Channels (Austin), 2011,5(3):236-240.
|
| [2] |
SOLAN J L, LAMPE P D. Specific Cx43 phosphorylation events regulate gap junction turnover in vivo[J]. FEBS Lett, 2014,588(8):1423-1429.
|
| [3] |
DE MELLO W C. Chemical communication between cardiac cells is disrupted by high glucose: implications for the diabetic heart[J]. Exp Cell Res, 2015,331(1):232-238.
|
| [4] |
GLENN T D, TALBOT W S. Signals regulating myelination in peripheral nerves and the Schwann cell response to injury[J]. Curr Opin Neurobiol, 2013,23(6):1041-1048.
|
| [5] |
MEIER C, DEMMIETZEL R, DAVIDSON K G, et al. Connexin32-containing gap junctions in Schwann cells at the internodal zone of partial myelin compaction and in Schmidt-Lanterman incisures[J]. J Neurosci, 2004,24(13):3186-3198.
|
| [6] |
JOLIVALT C G, VU Y, MIZISIN L M, et al. Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide[J]. J Neuropathol Exp Neurol, 2008,67(7):702-710.
|
| [7] |
CHEN D K, FRIZZI K E, GUEMSEY L S, et al. Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin[J]. J Peripher Nerv Syst, 2013,18(4):306-315.
|
| [8] |
POLADIA D P, SCHANBACHER B, WALLACE L J, et al. Innervation and connexin isoform expression during diabetes-related bladder dysfunction: early structural vs. neuronal remodelling[J]. Acta Diabetol, 2005,42(3):147-152.
|
| [9] |
CHANDROSS K J, KESSLER J A, COHEN R I, et al. Altered connexin expression after peripheral nerve injury[J]. Mol Cell Neurosci, 1996, 7(6): 501-518.
|
| [10] |
YANG D P, KIM J, SYED N, et al. p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination[J]. J Neurosci, 2012,32(21):7158-7168.
|
| [11] |
OKAMOTO T, AKIYAMA M, TAKEDA M, et al. Connexin32 protects against vascular inflammation by modulating inflammatory cytokine expression by endothelial cells[J]. Exp Cell Res, 2011,317(3):348-355.
|
| [12] |
BRISSET A C, ISAKSON B E, KWA B R. Connexins in vascular physiology and pathology[J]. Antioxid Redox Signal, 2009,11(2):267-282.
|
| [13] |
AWUMEY E M, BRIDGES L E, WILLIAMS C L, et al. Nitric-oxide synthase knockout modulates Ca2+-sensing receptor expression and signaling in mouse mesenteric arteries[J]. J Pharmacol Exp Ther, 2013,346(1):38-47.
|
| [14] |
LIAO Y, REGAN C P, MANABE I, et al. Smooth muscle-targeted knockout of connexin43 enhances neointimal formation in response to vascular injury[J]. Arterioscler Thromb Vasc Biol, 2007,27(5):1037-1042.
|
| [15] |
MATSUSHITA T, RAMA A, CHAROLIDI N, et al. Relationship of connexin43 expression to phenotypic modulation in cultured human aortic smooth muscle cells[J]. Eur J Cell Biol, 2007,86(10):617-628.
|
| [16] |
MANOLAKOU P, ANGELOPOULOU R, BAKOYIANNIS C, et al. Cellular proliferation in complicated versus uncomplicated atherosclerotic lesions: total cell population, foam cells and newly formed microvessels[J]. Tissue Cell, 2009,41(6):408-413.
|
| [17] |
JOHNSTONE S R, KRONCKE B M, STRAUB A C, et al. MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation[J]. Circ Res, 2012,111(2):201-211.
|
| [18] |
KUROKI T, INOGUCHI T, UMEDA F, et al. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells[J]. Diabetes, 1998,47(6):931-936.
|
| [19] |
PFENNIGER A, CHANSON M, KWA B R. Connexins in atherosclerosis[J]. BBA-Biomembranes, 2013,1828(1):157-166.
|
| [20] |
MOREL S, BUMIER L, KWAK B R. Connexins participate in the initiation and progression of atherosclerosis[J]. Semin Immunopathol,2009,31(1): 49-61.
|
| [21] |
LOOFT-WILSON R C, BILLAUD M, JOHNSTONE S R, et al. Interaction between nitric oxide signaling and gap junctions: effects on vascular function[J]. Biochim Biophys Acta,2012,1818(8): 1895-1902.
|
| [22] |
MOREL S, CHANSON M, NGUYEN T D, et al. Titration of the gap junction protein connexin43 reduces atherogenesis[J]. Thromb Haemost, 2014,112(2):390-401.
|
| [23] |
WONG C W, BURGER F, PELLI G, et al. Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice[J]. Cell Commun Adhes, 2003,10(4-6):395-400.
|
| [24] |
MUNZEL T, SINNING C, POST F, et al. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction[J]. Ann Med, 2008,40(3):180-196.
|
| [25] |
YANG Z, MING X F. Recent advances in understanding endothelial dysfunction in atherosclerosis[J]. Clin Med Res, 2006,4(1):53-65.
|
| [26] |
FIGUEROA X F, LILLO M A, GAETE P S, et al. Diffusion of nitric oxide across cell membranes of the vascular wall requires specific connexin-based channels[J]. Neuropharmacology, 2013,75:471-478.
|
| [27] |
HO C F, CHAN K W, YEH H I, et al. Ketone bodies upregulate endothelial connexin 43 (Cx43) gap junctions[J]. Vet J, 2013,198(3):696-701.
|
| [28] |
YUAN D, WANG Q, WU D, et al. Monocyte-endothelial adhesion is modulated by Cx43-stimulated ATP release from monocytes[J]. Biochem Biophys Res Commun, 2012,420(3):536-541.
|
| [29] |
COUTINHO P, QIU C, FRANK S, et al. Limiting burn extension by transient inhibition of connexin43 expression at the site of injury[J]. Br J Plast Surg, 2005,58(5):658-667.
|
| [30] |
QIU C, COUTINHO P, FRANK S, et al. Targeting connexin43 expression accelerates the rate of wound repair[J]. Curr Biol, 2003,13(19):1697-1703.
|
| [31] |
KRETZ M, MAASS K, WILLECKE K. Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants[J]. Eur J Cell Biol, 2004,83(11-12):647-654.
|
| [32] |
WANG C M, LINCOLN J, COOK J E, et al. Abnormal Connexin expression underlies delayed wound healing in diabetic skin[J]. Diabetes, 2007,56(11):2809-2817.
|
| [33] |
MENDOZA-NARANJO A, COMMIE P, SERRANO A E, et al. Targeting Cx43 and N-cadherin, which are abnormally upregulated in venous leg ulcers, influences migration, adhesion and activation of Rho GTPases[J]. PLoS One, 2012,7(5):e37374.
|
| [34] |
WEI C J, FRANCIS R, XU X, et al. Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells[J]. J Biol Chem, 2005,280(20):19925-19936.
|
| [35] |
MENDOZA-NARANJO A, COMMIE P, SERRANO A E, et al. Overexpression of the gap junction protein Cx43 as found in diabetic foot ulcers can retard fibroblast migration[J]. Cell Biol Int, 2012,36(7):661-667.
|
| [36] |
LOUGHLIN D T, ARTLETT C M. 3-Deoxyglucosone-collagen alters human dermal fibroblast migration and adhesion: implications for impaired wound healing in patients with diabetes[J]. Wound Repair Regen, 2009,17(5):739-749.
|
| [37] |
SCHECKENBACH K E, CRESPIN S, KWAK B R, et al. Connexin channel-dependent signaling pathways in inflammation[J]. J Vasc Res, 2011,48(2):91-103.
|
| [38] |
OKAMOTO T, AKIYAMA M, TAKEDA M, et al. Connexin32 protects against vascular inflammation by modulating inflammatory cytokine expression by endothelial cells[J]. Exp Cell Res, 2011,317(3):348-355.
|
| [39] |
CASTELLANO P, EUGENIN E A. Regulation of gap junction channels by infectious agents and inflammation in the CNS[J]. Front Cell Neurosci, 2014,8:122.
|
| [40] |
ABLASSER A, SCHMID-BURGK J L, HEMMERLING I, et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP[J]. Nature, 2013,503(7477):530-534.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
